B-Raf IN 8 structure
|
Common Name | B-Raf IN 8 | ||
|---|---|---|---|---|
| CAS Number | 1215313-19-1 | Molecular Weight | 307.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H17N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of B-Raf IN 8B-Raf IN 8 (compound 7g) is a potent B-Raf inhibitor, with an IC50 of 70.65 nM. B-Raf IN 8 exhibits antitumor activity against hepatocellular carcinoma (HEPG-2), colon carcinoma (HCT-116), mammary gland (MCF-7) and human prostate cancer (PC-3) cells, with IC50 values of 9.78, 13.78, 18.52 and 29.85 µM[1]. |
| Name | B-Raf IN 8 |
|---|
| Description | B-Raf IN 8 (compound 7g) is a potent B-Raf inhibitor, with an IC50 of 70.65 nM. B-Raf IN 8 exhibits antitumor activity against hepatocellular carcinoma (HEPG-2), colon carcinoma (HCT-116), mammary gland (MCF-7) and human prostate cancer (PC-3) cells, with IC50 values of 9.78, 13.78, 18.52 and 29.85 µM[1]. |
|---|---|
| Related Catalog | |
| Target |
B-Raf:70.65 ± 0. nM (IC50) |
| References |
| Molecular Formula | C18H17N3O2 |
|---|---|
| Molecular Weight | 307.35 |